[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 110, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas Andrew Butler", "age": 42, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 950407, "exercisedValue": 0, "unexercisedValue": 5655125}, {"maxAge": 1, "name": "Mr. Ramses M. Erdtmann", "age": 60, "title": "Co-Founder, President, COO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Franco  Valle", "age": 42, "title": "CFO & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 673659, "exercisedValue": 0, "unexercisedValue": 687866}, {"maxAge": 1, "name": "Dr. Juan Pablo Frias M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "totalPay": 492250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heow  Tan", "age": 64, "title": "Chief Technology & Quality Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Naomi  Cretcher", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thorsten  Kirschberg Ph.D.", "age": 53, "title": "Executive Vice President of Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephan  Morris M.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ravi  Upasani", "title": "Executive Vice President of Intellectual Property", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caroline  Perez- Dupont", "title": "Senior Vice President of Contracts", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1717200000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 5.21, "open": 5.08, "dayLow": 4.36, "dayHigh": 5.17, "regularMarketPreviousClose": 5.21, "regularMarketOpen": 5.08, "regularMarketDayLow": 4.36, "regularMarketDayHigh": 5.17, "beta": -0.374, "forwardPE": -1.2936046, "volume": 1393610, "regularMarketVolume": 1393610, "averageVolume": 1410029, "averageVolume10days": 2558460, "averageDailyVolume10Day": 2558460, "bid": 4.43, "ask": 4.46, "bidSize": 300, "askSize": 600, "marketCap": 159953456, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 23.92, "fiftyDayAverage": 9.741, "twoHundredDayAverage": 13.090525, "currency": "USD", "enterpriseValue": 26127398, "floatShares": 19449974, "sharesOutstanding": 35944600, "sharesShort": 11926901, "sharesShortPriorMonth": 13969598, "sharesShortPreviousMonthDate": 1714435200, "dateShortInterest": 1717113600, "sharesPercentSharesOut": 0.3318, "heldPercentInsiders": 0.25144, "heldPercentInstitutions": 0.87124, "shortRatio": 16.43, "shortPercentOfFloat": 0.5431, "impliedSharesOutstanding": 35944600, "bookValue": 3.766, "priceToBook": 1.181625, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -127265000, "trailingEps": -3.55, "forwardEps": -3.44, "enterpriseToEbitda": -0.193, "52WeekChange": -0.7945522, "SandP52WeekChange": 0.24598539, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "BMEA", "underlyingSymbol": "BMEA", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bc0a49f6-c4ed-3d62-b67c-2f5f0de07165", "messageBoardId": "finmb_695310535", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.45, "targetHighPrice": 60.0, "targetLowPrice": 5.0, "targetMeanPrice": 26.0, "targetMedianPrice": 18.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 144918000, "totalCashPerShare": 4.032, "ebitda": -135520992, "totalDebt": 11092000, "quickRatio": 5.738, "currentRatio": 5.843, "debtToEquity": 8.197, "returnOnAssets": -0.60987, "returnOnEquity": -1.1652, "freeCashflow": -62755876, "operatingCashflow": -104578000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-27"}]